KISNER DANIEL L
CIK: 0001073407
Director
Primary company: CALIPER LIFE SCIENCES INC (CALP)
KISNER DANIEL L is a corporate insider at CALIPER LIFE SCIENCES INC (CALP) filing SEC Form 4 transactions. 182 transactions across 7 companies, totaling $57,575 in purchases and $272,790 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 28,500 | $10.18 | $290K | 28,500 | 6/11/2025 Filed: 6/13/2025 | Filing → | |
| Award | 5,758 | - | - | 23,329 | 6/11/2025 Filed: 6/13/2025 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 2,200 | - | - | 2,200 | 6/20/2024 Filed: 6/24/2024 | Filing → |
| Award | 22,500 | - | - | 22,500 | 5/23/2024 Filed: 5/28/2024 | Filing → | |
| Award | 5,357 | - | - | 17,571 | 5/23/2024 Filed: 5/28/2024 | Filing → | |
Zynerba Pharmaceuticals, Inc. ZYNE | Disposition | 71,736 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Disposition | 34,663 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 47,824 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 27,954 | - | - | 47,824 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Oncternal Therapeutics, Inc. ONCT | Award | 25,000 | $0.00 | $0 | 25,000 | 6/28/2023 Filed: 6/30/2023 | Filing → |
Histogen Inc. HSTO | Award | 6,835 | $0.00 | $0 | 6,835 | 6/20/2023 Filed: 6/21/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Sale | 115 | $0.35 | $40 | 75,778 | 6/14/2023 Filed: 6/15/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 71,736 | $0.00 | $0 | 71,736 | 6/13/2023 Filed: 6/15/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 47,824 | $0.00 | $0 | 75,893 | 6/13/2023 Filed: 6/15/2023 | Filing → |
| Award | 22,500 | $0.00 | $0 | 22,500 | 5/26/2023 Filed: 5/31/2023 | Filing → | |
| Award | 5,357 | $0.00 | $0 | 12,214 | 5/26/2023 Filed: 5/31/2023 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 25,000 | $0.00 | $0 | 25,000 | 6/16/2022 Filed: 6/17/2022 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 34,663 | $0.00 | $0 | 34,663 | 6/14/2022 Filed: 6/16/2022 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Sale | 40 | $1.01 | $40 | 28,069 | 6/14/2022 Filed: 6/16/2022 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 23,109 | $0.00 | $0 | 28,109 | 6/14/2022 Filed: 6/16/2022 | Filing → |
Type
Award
Shares
28,500
Price
$10.18
Value
$290K
Type
Award
Shares
5,758
Price
-
Value
-
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
2,200
Price
-
Value
-
Type
Award
Shares
22,500
Price
-
Value
-
Type
Award
Shares
5,357
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Disposition
Shares
71,736
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Disposition
Shares
34,663
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
47,824
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
27,954
Price
-
Value
-
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Histogen Inc.
HSTO
Type
Award
Shares
6,835
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Sale
Shares
115
Price
$0.35
Value
$40
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
71,736
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
47,824
Price
$0.00
Value
$0
Type
Award
Shares
22,500
Price
$0.00
Value
$0
Type
Award
Shares
5,357
Price
$0.00
Value
$0
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
34,663
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Sale
Shares
40
Price
$1.01
Value
$40
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
23,109
Price
$0.00
Value
$0
AI Agent
Try asking...